To investigate the predictive value of CTLA4 DNA methylation in HNSCC, we examined CTLA4 DNA methylation in tumor samples of N = 29 patients with advanced or metastatic HNSCC prior to ICB. The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.